Sernova Corp 2021 Corporate Investor Presentation

Sernova Corp is a clinical-stage regenerative medicine company developing the Cell Pouch System, an implantable device with immuno-protected cells designed to produce therapeutic proteins and hormones. The lead product targets type 1 diabetes by delivering continuous insulin production, aiming to reduce or eliminate insulin injection dependence. The platform has potential applications across multiple chronic debilitating disease indications.